[68Ga]-DOTA-FTY720

N/A

Report date: 2025/10/31 15:08:05

NME

Base Information

Drug Name[68Ga]-DOTA-FTY720

Drug Alias Name[68Ga]Ga-DOTA-PEG3-TZ(PEG4-Octr)-PEG2-Trz-PEG3-Val-Cit-pABOC-FTY720T-SMPDC

ClassificationRadiation-emitting products > Nuclides > Gallium > 68GaRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates +[4]

Mechanisms of ActionSphingosine kinase 1 bindersSomatostatin receptor 2 binders

TargetsSphingosine kinase 1Somatostatin receptor 2

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesUniversity of Texas Southwestern Medical Center

China Registration ClassN/A

Develop Information

Active CompaniesUniversity of Texas Southwestern Medical Center

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A